Know Labs, Inc. (KNW) Stock
Know Labs, Inc., an American enterprise, is dedicated to the creation and market introduction of its proprietary technologies. At the heart of its operations is a technology known as Bio-RFID, which employs spectroscopy to transmit electromagnetic energy through substances or materials, thereby identifying and capturing their unique molecular signatures.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Know Labs, Inc.
Know Labs, Inc., an American enterprise, is dedicated to the creation and market introduction of its proprietary technologies. At the heart of its operations is a technology known as Bio-RFID, which employs spectroscopy to transmit electromagnetic energy through substances or materials, thereby identifying and capturing their unique molecular signatures. This Bio-RFID system boasts adaptability, allowing for its incorporation into diverse form factors such as wearable devices, mobile applications, and stationary laboratory equipment. Its initial commercial offering leveraging Bio-RFID is a glucose monitoring product designed to furnish users with instantaneous data regarding their blood glucose concentrations. The company, initially named Visualant, Incorporated, officially adopted the name Know Labs, Inc. in May 2018. Established in 1998, Know Labs, Inc. operates from its headquarters in Seattle, Washington.
Know Labs, Inc. is headquartered in US.
Know Labs, Inc. (KNW) stock trades at $2.14 with a market capitalization of $16.05M. The stock is valued at a price-to-earnings (P/E) ratio of -5.10, price-to-book of 0.01, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.33 and $14.80, and currently trades 85.5% below its 52-week high.
On profitability, Know Labs, Inc. generates a return on equity (ROE) of -83.68%, return on capital employed of -18.94%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.knowlabs.co